| Summary of Net Revenue, Cost of Sales, Operating Profit, Depreciation and Amortization, Interest Expense, Income Tax Benefit (Expense), Other Comprehensive Income, and Assets by Segment |
The following table shows, by segment: net revenue, cost of sales, operating profit, depreciation and amortization, interest expense, income tax (expense) benefit, other comprehensive loss, and assets for the years ended November 30, 201 9 and 201 8 :
|
|
|
|
|
|
|
|
|
| |
|
For the years ended November 30, |
|
| |
|
2019 |
|
|
2018 |
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
30,991,972 |
|
|
$ |
28,817,872 |
|
|
|
|
172,395 |
|
|
|
104,323 |
|
Public cord blood banking |
|
|
652,204 |
|
|
|
296,295 |
|
|
|
|
|
|
|
|
|
|
|
|
$ |
31,816,571 |
|
|
$ |
29,218,490 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
8,490,824 |
|
|
$ |
7,744,208 |
|
|
|
|
249,487 |
|
|
|
169,397 |
|
Public cord blood banking |
|
|
1,295,864 |
|
|
|
626,057 |
|
|
|
|
|
|
|
|
|
|
|
|
$ |
10,036,175 |
|
|
$ |
8,539,662 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
8,152,475 |
|
|
$ |
5,620,394 |
|
|
|
|
(113,346 |
) |
|
|
(101,329 |
) |
Public cord blood banking |
|
|
(2,976,423 |
) |
|
|
(329,762 |
) |
|
|
|
|
|
|
|
|
|
|
|
$ |
5,062,706 |
|
|
$ |
5,189,303 |
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization: |
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
365,057 |
|
|
$ |
281,072 |
|
|
|
|
36,254 |
|
|
|
36,254 |
|
Public cord blood banking |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
Total depreciation and amortization |
|
$ |
401,311 |
|
|
$ |
317,326 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
1,703,446 |
|
|
$ |
1,546,900 |
|
|
|
|
— |
|
|
|
— |
|
Public cord blood banking |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
$ |
1,703,446 |
|
|
$ |
1,546,900 |
|
|
|
|
|
|
|
|
|
|
Income tax (expense) benefit: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
(1,100,641 |
) |
|
$ |
(4,472,504 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
— |
|
|
|
— |
|
Public cord blood banking |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
Total income tax (expense) benefit |
|
$ |
(1,100,641 |
) |
|
$ |
(4,472,504 |
) |
|
|
|
|
|
|
|
|
|
Other comprehensive income (loss): |
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
— |
|
|
$ |
300,119 |
|
|
|
|
— |
|
|
|
— |
|
Public cord blood banking |
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
Total other comprehensive income (loss) |
|
$ |
— |
|
|
$ |
300,119 |
|
|
|
|
|
|
|
|
|
|
The following table shows the assets by segment as of November 30, 2019 and November 30, 2018:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
28,975,002 |
|
|
$ |
26,239,260 |
|
|
|
|
289,804 |
|
|
|
319,802 |
|
Public cord blood banking |
|
|
13,621,354 |
|
|
|
15,831,081 |
|
|
|
|
|
|
|
|
|
|
|
|
$ |
42,886,160 |
|
|
$ |
42,390,143 |
|
|
|
|
|
|
|
|
|
|
|